# Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma

> **NCT04356170** · PHASE2 · COMPLETED · sponsor: **Groupe Oncologie Radiotherapie Tete et Cou** · enrollment: 105 (actual)

## Conditions studied

- Cancer of Head and Neck

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Cisplatin
- **DRUG:** Fluoro Uracil

## Key facts

- **NCT ID:** NCT04356170
- **Lead sponsor:** Groupe Oncologie Radiotherapie Tete et Cou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-04
- **Primary completion:** 2025-08-05
- **Final completion:** 2025-08-05
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04356170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04356170, "Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04356170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*